Intraperitoneal cisapride for the treatment of diabetics with gastroparesis and end-stage renal disease.
Lazarovits
A I
AI
Page
D
D
D000328:Adult; D020117:Cisapride; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000150:complications; D004341:Drug Evaluation; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D009197:Myenteric Plexus / Q000187:drug effects; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013268:Stimulation, Chemical
D010880:Piperidines; D020117:Cisapride